Everolimus-Treated Renal Transplant Recipients Have a More Robust CMV-Specific CD8+ T-Cell Response Compared With Cyclosporine- or Mycophenolate-Treated Patients
2013 ◽
Vol 95
(1)
◽
pp. 184-191
◽
Keyword(s):
T Cell
◽